Clinical Trial

cfMSC Therapy for Diabetes

Name: cfMSC Therapy for Diabetes — clinical trial record (NCT07495956)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the feasibility, safety and clinical efficacy of the novel clonal fetal mesenchymal stem cell (cfMSC) therapy in patients with type II diabetes mellitus.

Trial Details

NCT Number	NCT07495956
Lead Sponsor	Shenzhen Geno-Immune Medical Institute
Conditions	Type II Diabetes Mellitus
Enrollment	30 participants
Start Date	2026-03-16
Primary Completion	2029-03-31 (estimated)
Study Completion	2030-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-27